Spondyloarthritis Special Interest Group (SIG) of
the British Society of Rheumatology (BSR)
The Spondyloarthritis (SpA) SIG covers issues
relating to the group of conditions, including ankylosing spondylitis and
psoriatic arthritis. This SIG aims to keep all members up to date with a broad
range of topics including early detection, assessment and new therapies. It also covers research, guidelines and nationally
relevant issues such as NICE guidelines and commissioning. The group meet once
a year at the BSR and also aims to keep all members updated via email during
the rest of the year. The field of SpA is evolving rapidly, and members will
find this SIG an invaluable way of keeping up to date.
13 SIG08 -
Spondyloarthritis special interest group
April 26, 2016, 11:30
AM - 1:00 PM
DESCRIPTION
This is the SIG meeting for spondyloarthritis. This is a
rapidly expanding field and this SIG aims to be the umbrella group bringing all
the work in this area together. It will provide the latest update in
pathogenesis and treatments in this field. There will also be an update of
intiatives to improve outcomes in spondyloarthritis. This includes updates from
partner groups and collaborators. The session will also cover the organisation
and delivery of rheumatology services local the venue of the BSR 2016 (Glasgow).
6 Presentations
11:30 - 1:00 PM - Chair
Antoni T. Chan, Department of Rheumatology, Royal Berkshire
NHS Foundation Trust, Reading, UNITED KINGDOM.
11:30 - 1:00 PM - Chair
Bruce Kirkham, Department of Rheumatology, Guys and St.Thomas
NHS Foundation Trust, London, UNITED KINGDOM.
11:30 - 11:48 AM -
Factors affecting the composition of the gut microbiota
Karen Scott, Rowett Institute of Nutrition and Health,
Aberdeen, UNITED KINGDOM.
11:48 - 12:06 PM -
50 shades of grey in Glasgow
David Marshall, Department of Rheumatology, Inverclyde Royal
Hospital, Greenock, UNITED KINGDOM.
12:06 - 12:24 PM -
Update from BRIT-SPA
Helena Marzo-Ortega, Department of Rheumatology, NIHR Leeds
Musculoskeletal Biomedical Research Unit, Leeds, UNITED KINGDOM.
12:42 - 1:00 PM - New
therapies in spondyloarthritis
Iain McInnes, Institute of Infection, Immunity and
Inflammation, University of Glasgow, Glasgow, UNITED KINGDOM.
